TargetTyrosine-protein kinase ABL1(Homo sapiens (Human))
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Obshchestvo S Ogranichennoy Otvetstvennostyou “Fusion Pharma”
US Patent
Affinity DataIC50: <20nMAssay Description:Kinase activity and inhibition was measured by established protocols (see e.g. Braunwalder et al., A Solid-Phase Assay for the Determination of Prote...More data for this Ligand-Target Pair